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 Novelty and impact: 
Incidence of oesophageal and gastric cancer is higher among men than among women. In the 
first prospective study of a range of male hormonal and reproductive factors and upper 
gastrointestinal cancer risk, the authors found some evidence that male pattern baldness was 
associated with gastric cancer risk, particularly for frontal male pattern baldness. These 
findings provide support for future studies that directly test circulating sex steroid hormone 
levels in relation to upper gastrointestinal cancer risk. 
 
Article category: Cancer epidemiology 
Abbreviations: BMI, body mass index; CIs, confidence intervals; HR, hazard ratio; HRT, 
hormone replacement therapy; ICD, International Classification of Diseases; ONS, Office of 
National Statistics; UK, United Kingdom. 
  
ABSTRACT 
Incidence of upper gastrointestinal cancers of the oesophagus and stomach show a strong 
unexplained male predominance. Hormonal and reproductive factors have been associated 
with upper gastrointestinal cancers in women but there is little available data on men. To 
investigate this, we included 219,425 men enrolled in the UK Biobank in 2006–2010. 
Baseline assessments provided information on hormonal and reproductive factors 
(specifically hair baldness, number of children fathered, relative age at first facial hair and 
relative age voice broke) and incident oesophageal or gastric cancers were identified through 
linkage to UK cancer registries. Unadjusted and adjusted hazard ratios (HR) and 95% 
confidence intervals (CIs) were estimated using Cox proportional hazards models. During 8 
years of follow-up, 309 oesophageal 210 gastric cancers occurred. There was some evidence 
that male pattern baldness, was associated with gastric cancer risk (adjusted HR 1.35, 95% CI 
0.97, 1.88), particularly for frontal male pattern baldness (adjusted HR 1.52, 95% CI 1.02, 
2.28). There was little evidence of association between other hormonal and reproductive 
factors and risk of oesophageal or gastric cancer, overall or by histological subtype. In the 
first study of a range of male hormonal and reproductive factors and gastric cancer, there was 
a suggestion that male pattern baldness, often used as a proxy of sex hormone levels, may be 
associated with gastric cancer. Future prospective studies that directly test circulating sex 
steroid hormone levels in relation to upper gastrointestinal cancer risk are warranted. 
 
Keywords: sex hormones, men, reproductive factors, upper gastrointestinal cancers, UK 
Biobank 
  
INTRODUCTION 
Upper gastrointestinal cancers of the oesophagus and stomach account for 455,800 and 
951,600 new cancers diagnosed worldwide, respectively1. Significant morbidity and mortality 
is associated with these cancers; in the UK, only 15% of oesophageal and 19% of gastric 
cancer patients survive more than five years after diagnosis2-4, underlining the need for better 
understanding of aetiological factors to aid prevention. The most striking epidemiological 
feature of these cancers is their strong male predominance5,6, which is most obvious for 
adenocarcinomas7,8 and is suggestive of sex steroid hormone involvement (including 
oestrogens and androgens).  
Testosterone, an important anabolic hormone, increases tissue proliferation and has been 
shown to stimulate the growth of cancer cells in vitro9,10. Increased levels of testosterone in 
men and women has been associated with a 30-80% increase in early death after cancer 
diagnosis11. With regard to upper gastrointestinal cancers specifically, mounting preclinical 
evidence suggests that androgens and androgen receptor-signalling may be important in their 
pathogenesis; testosterone supresses wound healing and castration in male rats has been 
shown to inhibit gastric carcinogenesis12. Androgen receptor, a key mediator of inflammatory 
signals in oesophageal cancer progression13, is expressed in both oesophageal and gastric 
cancer tissues14-18 and has been correlated with poorer prognosis in gastric cancer patients18. 
Moreover, its overexpression has been shown to promote cell migration, invasion and 
proliferation in oesophageal and gastric cancer in vivo13,19,20. 
Rates of oesophageal cancer (and specifically oesophageal adenocarcinoma) among men with 
a previous prostate cancer diagnosis are lower than expected, indicating that the androgen-
lowering effects of androgen deprivation therapy may be contributing to a reduced 
oesophageal cancer risk21,22. Only one study has evaluated the influence of reproductive 
factors and risk of upper gastrointestinal cancer in men23. Lu et al. observed significant 
reductions in oesophageal adenocarcinoma and oesophageal squamous cell carcinoma risk in 
men who had fathered children and in men who were older at first fatherhood in a case-
control study that utilised administrative record linkages in Sweden23. However, only 
oesophageal cancer was evaluated in this study and other important markers of male sex 
hormone exposure (such as male pattern baldness pattern) were not investigated. Further 
aetiological research to understand why upper gastrointestinal cancer rates are so much 
higher in men than women has been highlighted as a priority in the gastrointestinal cancer 
field7.  
We therefore prospectively investigated novel associations between hormonal and 
reproductive factors and risk of oesophageal and gastric cancer in a large UK population-
based cohort of middle-aged men. 
 
METHODS 
Data sources 
The UK Biobank is a large prospective cohort study which recruited over 500,000 men and 
women aged 40-69 years from one of 22 assessment centres located across England, Scotland 
and Wales between 2006 and 201024. Touchscreen questionnaires were used at baseline to 
obtain information on a wide range of risk factors for chronic disease (e.g., demographics, 
diet, lifestyle, prior medical history and reproductive factors). Anthropometric measurements 
including height, weight, waist and hip circumference were also obtained at baseline. The UK 
Biobank is routinely linked to UK cancer registry data from the Health and Social Care 
Information Centre (in England and Wales) and the Scottish Cancer Registry (in Scotland) 
and death records from the UK Office of National Statistics (ONS). The UK Biobank was 
approved by the North West Multi-Centre Research Ethics Committee, and all participants 
provided written informed consent. 
 
Study population 
We included men enrolled in the UK Biobank without a previous history of cancer (excluding 
non-melanoma skin cancer) at or before baseline. Incident cases of oesophageal (ICD 10 
C15) and gastric cancer (ICD 10 C16) were identified through linkage to UK national cancer 
registries. Cases of oesophageal and gastric cancer were further classed by histology, as 
adenocarcinoma (ICD-O morphology codes 8140–8573) or squamous cell carcinoma (ICD-O 
8050–8082). Gastric cancers were classed by location, where possible, as cancers of the 
gastric cardia (C16.0) and gastric non-cardia sites (C16.1–16.5). Participants were followed 
from baseline until cancer diagnosis, emigration, death or end of follow-up (October 2014).  
 
Hormonal and reproductive factors 
Hormonal exposures included male pattern baldness and male pattern baldness pattern, 
fathered children status, number of children fathered, relative age at first facial hair and 
relative age at first voice broke were obtained from participants at baseline (from touchscreen 
questions). Participants with missing data for an exposure of interest were excluded from the 
relevant analysis. 
 
Covariates 
Information on risk factors for upper gastrointestinal cancers was retrieved from electronic 
touchscreen records collected at baseline and included smoking history, alcohol consumption, 
and dietary factors (e.g. average weekly intakes of fruit and vegetables, red and processed 
meat). Body mass index (BMI) and waist-to-hip ratio was measured at baseline. 
Socioeconomic deprivation was retrieved from Townsend score (based upon postcode of 
usual residence25).  
 
Statistical analysis 
Baseline cohort characteristics were compared between oesophageal or gastric cancer cases 
and non-cases using Chi-square tests for categorical variables. Cox proportional hazards 
regression models (with age as the underlying timescale variable) were used to estimate the 
unadjusted and adjusted hazard ratios (HR) and corresponding 95% confidence intervals (CI) 
for associations between hormonal and reproductive factors and risks of oesophageal and 
gastric cancer. All analyses were adjusted for age (as the underlying timescale), Townsend 
deprivation index (presented as quintiles), smoking status (by pack-years; never, former <20 
pack-years, former 20+ pack-years, current <20 pack years and current ≥20 pack years), 
alcohol intake (never drinker, former drinker, current light-moderate/occasional drinker [<14 
units per week], current heavy drinker [14+ units per week]), body mass index (BMI) (<18.5 
kg/m2, 18.5-24.9 kg/m2, 25-29.9 kg/m2, ≥30 kg/m2), waist-to-hip ratio according to whether it 
met the guideline of the International Diabetes Federation criteria (≤94cm in men)26 and 
average weekly intakes of fruit and vegetables (<2, 2-5, >5). Additional adjustments were 
made for average weekly intakes of red meat (Never/ <1, 1-3, >3) and processed meat 
(Never/ <1, 1, >1). Sub-group analyses were conducted by histology (oesophageal 
adenocarcinoma and squamous cell carcinoma) and gastric cancer location (gastric cardia and 
non-cardia).  
 
 
RESULTS 
UK Biobank cohort 
A total of 219,426 men were included in the final cohort, following exclusion of 9,748 
participants with a previous history of cancer. Of these, 309 men were diagnosed with 
oesophageal cancer and 210 were diagnosed with gastric cancer during a mean follow-up of 
5.5 years (maximum 8.5 years). Baseline characteristics of oesophageal and gastric cancer 
cases and non-cases are presented in Table 1. Oesophageal and gastric cancer cases were 
more likely to be older, be current and former heavy smokers, be former alcohol drinkers, be 
obese, and have a higher waist-to-hip ratio while oesophageal cancer cases were also more 
likely to report higher weekly intakes of red and processed meat. 
 
Association between hormonal and reproductive factors and risk of oesophageal and 
gastric cancer  
Results for associations between male hormonal and reproductive factors and risk of 
oesophageal and gastric cancer are listed in Table 2. Overall, no significant associations were 
observed for any of the hormonal exposures and risk of oesophageal cancer. For gastric 
cancer, there was a suggestion that men who reported having male pattern baldness had an 
increased risk of gastric cancer compared to those who reported no male pattern baldness, 
albeit the result failed to reach statistical significance (adjusted HR 1.35, 95% CI 0.97, 1.88; 
p=0.08). Frontal only male pattern baldness was significantly associated with an increased 
risk of gastric cancer compared to no male pattern baldness (adjusted HR 1.52, 95% CI 1.02, 
2.28). Other markers of sex hormone exposure were not associated with gastric cancer 
including fathered children, increasing number of children fathered, relative age at first facial 
hair or relative age voice broke. The findings were not materially altered following additional 
adjustments for red and processed meat intakes (data not shown).  
 
Sub group analysis by histological subtype and tumour location 
Results by histological subtype including oesophageal adenocarcinoma, oesophageal 
squamous cell carcinoma and gastric adenocarcinoma are presented in Table 3. Overall, no 
significant associations were observed for any of the examined hormonal or reproductive 
factors and risk of oesophageal adenocarcinoma. Fathering children was associated with a 
reduction in oesophageal squamous cell carcinoma in unadjusted analysis (HR 0.48, 95% CI 
0.24, 0.97); however, after adjustment for potential confounders, results attenuated and 
became statistically non-significant (adjusted HR 0.56, 95% CI 0.27, 1.15). Results for 
gastric adenocarcinoma were broadly similar to that of gastric cancer with a weak positive 
association observed for male pattern baldness, although not statistically significant (adjusted 
HR 1.39, 95% CI 0.97, 1.98; p=0.07), Table 3. 
Results by gastric cancer location are listed in Table 4. Male pattern baldness was associated 
with a non-significant increase in risk of gastric cardia cancer (adjusted HR 1.59, 95% CI 
0.97, 2.61, p=0.07). Hazard ratios remained elevated with increasing extent of baldness (e.g., 
frontal and severe vertex baldness; adjusted HR 1.58, 95% CI 0.86, 2.93). An increase in 
gastric non-cardia cancer in men who reported male pattern baldness was not apparent 
(adjusted HR 1.13, 95% CI 0.72, 1.76). Similarly, no other significant associations were 
identified for other hormonal and reproductive factors and risk of gastric non-cardia cancer. 
Results were similar after additional adjustment for red and processed meat intakes (data not 
shown). 
 
DISCUSSION 
Our study, which utilised prospectively recorded information from the UK Biobank, found 
little evidence of associations between sex hormone and reproductive factors and risk of 
oesophageal or gastric cancer in men however frontal male pattern baldness specifically was 
associated with a significant increase in gastric cancer risk. As this is the first study to 
evaluate the association between male pattern baldness and risk of gastric cancer, further 
epidemiological studies are required to replicate our findings.  
Because of the integral role of androgenic action in hair loss, previous studies on male pattern 
baldness and cancer risk have focused on prostate cancer risk27,28. However, in the Health 
Professionals Follow-Up Study, Keum et al.29 recently reported that subtypes of male pattern 
baldness at age 45 (including frontal only baldness and frontal-plus-mild-vertex baldness) 
were significantly associated with an increased risk of colon cancer, a cancer which also 
demonstrates a sex disparity in incidence, albeit not as marked as oesophageal or gastric 
cancer4. 
We found no significant associations between markers of hormonal exposure and risk of 
oesophageal cancer or oesophageal histological subtypes. In contrast to our study, a large 
case-control study in Sweden found significant reductions in oesophageal adenocarcinoma 
(OR 0.76, 95% CI 0.65, 0.90) and oesophageal squamous cell carcinoma (OR 0.57, 95% CI 
0.49, 0.67) in men who had fathered children but no significant dose-response was observed 
for  increasing number of children fathered23. The authors found similar effects for 
reproductive factors in women and went on to suggest the possibility of confounding by non-
hormonal exposures23. Nevertheless, fatherhood and number of children have been shown to 
independently influence testosterone levels in men30. Differences in methodologies may 
partly explain the discrepancies with our findings; for example, information on number of 
children fathered was obtained from Swedish registries whereas we used self-report 
measures. Similar to our study though, Lu et al. found no significant relationship for 
increasing number of children fathered23. In women, although results from individual studies 
have been inconsistent, pooled analyses have found positive associations for menopause31 
and inverse associations for breastfeeding31,32, longer years of fertility33 and HRT use31,33,34, 
providing some support that endogenous and exogenous oestrogen exposure may lower 
oesophageal and gastric cancer risk in women. 
The weak evidence of an association between frontal baldness and gastric cancer risk is 
difficult to interpret and requires confirmation.  If real, this could reflect that male pattern 
male pattern baldness, or androgenetic alopecia, is mediated by dihydrotestosterone, the 
potent metabolite of testosterone35.  There is growing evidence suggesting that male pattern 
balding status could serve as a clinical marker for circulating sex hormone concentrations36-
38. Moreover, preclinical experimental evidence supports a gastric cancer-promoting effect 
for testosterone12 and androgen receptor overexpression in vivo has been shown to promote 
cell migration, invasion and proliferation in gastric cancer20. Taken together, it is possible 
that androgens might play a role in the development of these cancers, and could provide a 
logical explanation for the male dominance in their incidence. Better understanding of 
whether androgen receptors influence the development of oesophageal and gastric cancer is 
essential considering that intervention before malignancy presents an opportunity for 
prevention.  
Few studies have investigated circulating testosterone levels in relation to risk of oesophageal 
or gastric cancer. An Irish population-based case-control study identified a higher ratio of 
androgens to oestrogens in oesophageal adenocarcinoma patients compared to controls, 
something which was particularly marked for testosterone:oestradiol ratio39. In a small case-
control study of 33 individuals, pre-operative serum testosterone levels were found to be 
significantly higher in oesophageal adenocarcinoma patients compared to age-matched 
controls17. However, testosterone levels were measured following oesophageal 
adenocarcinoma diagnosis and following surgery, testosterone levels in oesophageal 
adenocarcinoma cases decreased to levels of the controls17. Barrett’s oesophagus, the 
precursor of oesophageal adenocarcinoma, has been positively associated with circulating 
free androgens in men40,41 and was particularly marked in men with higher waist-to-hip 
ratios41.  These results suggest that the balance of androgens to oestrogens could be important 
in the progression from Barrett’s to oesophageal adenocarcinoma but cautious interpretation 
is required as sex hormone levels were measured post-diagnosis (in cases) meaning reverse 
causality cannot be ruled out17,39-41,. Population-based studies with prospective blood 
collection are therefore required to replicate these findings. No study has investigated the 
influence of circulating sex hormone levels on gastric cancer risk. Although we adjusted all 
analyses for both BMI and waist-hip ratio as measures of total and abdominal obesity, 
respectively, further study of the interaction between obesity, androgens, and male gender in 
the genesis of upper gastrointestinal cancers is required. Given that abdominal obesity is 
particularly associated with both oesophageal adenocarcinoma and gastric cancer risk42 and 
obese individuals generally have lower circulating levels of androgens43,44 (possibly due to 
the conversion of testosterone to oestrogens by aromatase45, detailed investigation of steroid 
hormone metabolism in adipose tissue located in close proximity to the oesophagus and 
stomach is also warranted. 
 
Strengths and weaknesses 
We utilised a large, well-characterised, population-based cohort of middle-aged men with 
prospectively collected information on hormonal and reproductive factors, therefore 
minimising biases associated with retrospective study designs. Linkage to national cancer 
registries allowed for robust verification of oesophageal and gastric cancer cases, and allowed 
for analysis by histological subtype and tumour location. The availability of detailed 
information on a range of lifestyle factors including anthropometric measures and dietary 
intake (e.g. fruit and vegetable intake) was also of benefit to limit potential confounding. We 
were unable to account for dietary factors that have previously been implicated with sex 
hormones, for example isoflavones  and phyto-oestrogens46,47, however epidemiological 
studies have failed to show associations between intake of these compounds and circulating 
sex hormone concentrations48,49. There was missing data for a small proportion of 
participants meaning that we cannot rule out the potential for residual confounding. Data on 
hormonal and reproductive factors was self-reported and was therefore subject to 
misclassification. This may be particularly relevant for information recalled from decades 
prior to study recruitment such as relative age at first voice broke and relative age at first 
facial hair. Studies in women however have indicated that early hormonal factors such as age 
at menarche are recalled with reasonable accuracy50 which may extend to men. Moreover, the 
validity of self-reported male pattern baldness in epidemiological studies has been shown to 
have sufficient accuracy to ensure reliability and validity of results51. The UK Biobank had a 
relatively low participation response rate of 5% which could suggest that it is not 
representative of the sampling population and there may be potential for “healthy volunteer” 
selection bias. However, considering its large size and population variability in exposures, 
valid assessment of exposure-disease relationships may be widely generalizable and does not 
require participants to be representative of the population at large24,52. Approximately 95% of 
the UK Biobank cohort is of white ethnicity; therefore, our results may not be generalisable 
to other ethnicities. Despite the large size of our cohort, some sub-group analyses by tumour 
type were limited by small numbers, in particular oesophageal squamous cell carcinoma. 
Gastroesophageal reflux is a strong risk factor for oesophageal adenocarcinoma and, although 
we did not have reliable information on reflux in the UK Biobank, the prevalence of this 
exposure and the effect on oesophageal adenocarcinoma risk have been shown to be similar 
in both men and women53 Indeed, associations between reflux with oesophageal 
adenocarcinoma in females have been reported to be similar if not stronger compared to 
males54, suggesting that reflux is unlikely to be hormonally mediated. We did not have 
information on Helicobacter pylori (H. pylori) status of participants but H. pylori has shown 
a similar prevalence in men and women55,56 and previous studies in females indicate that 
baseline H. pylori serostatus does not modify associations between hormonal and 
reproductive factors and risk of gastric cancer57,58. We did not have robust information on 
prior Barrett’s oesophagus, the precursor condition to oesophageal adenocarcinoma; 
however, only a small proportion of subjects with known Barrett’s oesophagus progress to 
oesophageal adenocarcinoma59. Finally, although we had information on a range of surrogate 
markers for lifetime sex hormone exposure, which enabled novel investigations of upper 
gastrointestinal cancer risk, prospective studies with direct assessments of circulating 
oestrogen and androgen concentrations (as well as their ratios) are needed to provide a more 
accurate assessment of the role of sex hormones in these malignancies. 
 
Conclusion 
In conclusion, in the first prospective study to investigate a range of male hormonal factors 
and risk of oesophageal and gastric cancer, there was suggestive evidence that male pattern 
baldness may be associated with an increased gastric cancer risk. Considering the complex 
patterns of expression of both oestrogen and androgen receptors in oesophageal and gastric 
cancer, prospective studies of the association between sex steroid hormone levels (as well as 
their ratios) and risk of upper gastrointestinal cancers in both sexes are required. 
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Table 1.  Characteristics of oesophageal and gastric cancer cases and non-cases in men within 
the UK Biobank  
 
 
 
Oesophageal cancer 
 
   
Gastric cancer 
 Characteristic 
Cases 
n (%) 
Non-cases 
n (%) 
Cases 
n (%) 
Non-cases 
n (%) 
 (n=309) (n= 219,116) (n=210) (n= 219,215) 
Age at baseline (years)     
<50 11 (3.6) 52,398 (23.9) 14 (6.7) 52,395 (23.9) 
50-<55 24 (7.8) 32,283 (14.7) 21 (10) 32,286 (14.7) 
55-<60 63 (20.4) 38,630 (17.6) 25 (11.9) 38,668 (17.6) 
60-<65 86 (27.8) 52,375 (23.9) 65 (31) 52,396 (23.9) 
≥65 125 (40.5) 43,430 (19.8) 85 (40.5) 43,470 (19.8) 
     
Socioeconomic status     
1 (least deprived) 57 (18.5) 44,053 (20.1) 36 (17.2) 44,074 (20.1) 
2 51 (16.5) 43,456 (19.9) 33 (15.8) 43,474 (19.9) 
3 52 (16.8) 43,007 (19.7) 45 (21.5) 43,014 (19.7) 
4 70 (22.7) 43,159 (19.7) 43 (20.6) 43,186 (19.7) 
5 (most deprived) 79 (25.6) 45,151 (20.6) 52 (24.9) 45,178 (20.6) 
Missing 0 290 1 289 
     
Smoking statusa     
Never 80 (26) 107,148 (49.2) 65 (31.4) 107,163 (49.2) 
Former light smoker 82 (26.6) 56,970 (26.2) 54 (26.1) 56,998 (26.2) 
Former heavy smoker 81 (26.3) 26,060 (12) 51 (26.6) 26,090 (12) 
Current light smoker 23 (7.5) 14,014 (6.4) 11 (5.3) 14,026 (6.4) 
Current heavy smoker 42 (13.6) 13,562 (6.2) 26 (12.6) 13,578 (6.2) 
Missing 1 1,362 4 1,360 
     
Alcohol intakeb     
Never drinker 4 (1.3) 6,202 (2.9) 7 (3.4) 6,199 (2.9) 
Current light-moderate drinker 131 (42.7) 98,171 (45.1) 89 (42.6) 98,213 (45.1) 
Current heavy drinker 151 (49.2) 105,734 (48.6) 97 (46.4) 105,788 (48.6) 
Former drinker 21 (6.8) 7,659 (3.5) 16 (7.7) 7,664 (3.5) 
Missing 2 1,350 1 1,351 
     
BMI status (kg/m2)     
Underweight (<18.5) 1 (0.3) 507 (0.2) 3 (1.4) 505 (0.2) 
Normal (18.5-<25) 42 (13.7) 54,272 (25) 32 (15.2) 54,282 (24.9) 
Overweight (25-<30) 151 (49.4) 107,414 (29.4) 113 (53.8) 107,452 (49.4) 
Obese (30+) 112 (36.6) 55,335 (25.4) 62 (29.5) 55,385 (25.5) 
Missing 3 1,588 0 1,591 
     
Waist:hip ratioc     
Below IDF guideline 110 (35.7) 117,669 (54) 85 (40.5) 117,694 (54) 
Above IDF guideline 198 (64.3) 100,366 (46) 125 (59.5) 100,439 (46) 
Missing 1 1,081 0 1,082 
     
Fruit & vegetable intake (servings per week) 
<2  88 (29.5) 54,906 (26) 54 (26.7) 54,940 (26) 
2-5  126 (42.3) 88,756 (42) 76 (37.6) 88,806 (42) 
>5 84 (28.2) 67,654 (32) 72 (35.6) 67,666 (32) 
Missing 11 7,800 8 7,803 
     
Processed meat intake (servings per week) 
Never/ <1 62 (20.1) 58,471 (26.8) 55 (26.3) 58,478 (26.8) 
1 94 (30.5) 64,966 (29.8) 69 (33) 64,991 (29.8) 
>1 152 (49.4) 94,600 (43.4) 85 (40.7) 94,667 (43.4) 
Missing 1 1,079 1 1,079 
     
Red meat intake (servings per week) 
Never/ <1 106 (34.9) 97,306 (45.1) 77 (37.6) 97,335 (45.1) 
1-3 101 (33.2) 63,067 (29.2) 70 (34.2) 63,098 (29.2) 
≥3 97 (31.9) 55,308 (25.6) 58 (28.3) 55,347 (25.6) 
Missing 5 3,435 5 3,435 
a By pack years (light=<20 pack-years; heavy=>20 pack-years) 
b Light-moderate (special occasions, 1-3 times per month, <14 units/week), heavy (>14 units/week) 
c Based on International Diabetes Federation criteria (>94cm in men; >80cm in women).  
 
  
Table 2. Hormonal and reproductive factors and risk of oesophageal and gastric cancer in men 
within the UK Biobank 
 
  
 
Oesophageal cancer (n=309) 
  
 
Gastric cancer (n=210) 
 
 
Characteristic 
 
Person-
years 
Cases 
n 
 
HR 
(95%CI) 
Adjusteda HR 
(95% CI) 
Cases 
n 
 
HR 
(95%CI) 
Adjusteda HR 
(95% CI) 
Male pattern baldness        
No 383,248 87  Ref Ref 48  Ref Ref 
Yes 799,540 215  1.02 (0.80, 1.31) 1.05 (0.81, 1.35) 157 1.36 (0.99, 1.88) 1.35 (0.97, 1.88) 
Missing  7   5   
Male pattern baldness 
pattern 
 
      
No baldness 383,248 87 Ref Ref 48 Ref Ref 
Frontal only 272,458 55  0.91 (0.65, 1.27) 0.94 (0.67, 1.33) 50  1.48 (1.00, 2.20) 1.52 (1.02, 2.28) 
Frontal and mild vertex 313,218 91  1.02 (0.76, 1.37) 1.03 (0.76, 1.40) 65  1.33 (0.92, 2.20) 1.28 (0.87, 1.88) 
Frontal and severe vertex 213,863 69  1.14 (0.83, 1.57) 1.18 (0.85, 1.64) 42  1.28 (0.84, 1.93) 1.28 (0.83, 1.95) 
Missing  7  Ptrend=0.31 5  Ptrend=0.34 
Fathered children        
No 248,723 51 Ref Ref 35 Ref Ref 
Yes 934,168 250  1.01 (0.74, 1.36) 1.02 (0.75, 1.40) 171 1.02 (0.70, 1.46) 1.10 (0.75, 1.62) 
Missing  8   4   
Number of children fathered 
0 248,723 51  Ref Ref 35 Ref Ref 
1 151,412 41  1.16 (0.77, 1.76) 1.14 (0.74, 1.74) 27  1.12 (0.68, 1.86) 1.19 (0.70, 2.00) 
2 495,538 126  0.94 (0.68, 13.1) 1.01 (0.72, 1.42) 82  0.91 (0.61, 1.36) 1.03 (0.67, 1.57) 
a Adjusted for socioeconomic status, alcohol status, smoking status, BMI, waist-hip ratio and fruit and vegetable 
intake. 
 
3+ 287,217 83  1.04 (0.73, 1.48) 0.99 (0.69, 1.42) 62  1.14 (0.75, 1.73) 1.17 (0.76, 1.81) 
Missing  8  Ptrend=0.79 4  Ptrend=0.61 
Relative age at first facial hair 
Younger than average 78,766 18 Ref Ref 6  Ref Ref 
About average age 918,381 248 0.93 (0.58, 1.50) 0.93 (0.57, 1.50) 170 1.95 (0.86, 4.40) 1.91 (0.85, 4.33) 
Older than average 149,263 25 0.71 (0.39, 1.29) 0.69 (0.37, 1.28) 20  1.71 (0.69, 4.26) 1.79 (0.72, 4.47) 
Missing  18  Ptrend=0.20 14  Ptrend=0.42 
Relative age voice broke        
Younger than average 48,226 14 Ref Ref 4  Ref Ref 
About average age 980,197 247  0.68 (0.40, 1.16) 0.68 (0.39, 1.16) 174  1.72 (0.64, 4.65) 1.75 (0.65, 4.73) 
Older than average 65,391 15 0.77 (0.37, 1.59) 0.90 (0.43, 1.86) 8 1.44 (0.43, 4.78) 1.64 (0.49, 5.45) 
Missing  33  Ptrend=0.85 24  Ptrend=0.53 
Table 3. Hormonal and reproductive factors and risk of oesophageal and gastric cancer by histological subtype in men within the UK Biobank 
 
a Adjusted for socioeconomic status, alcohol status, smoking status, BMI, waist-hip ratio and fruit and vegetable intake.
   
Oesophageal adenocarcinoma (n=253) 
  
Oesophageal squamous cell carcinoma (n=39) 
  
Gastric  adenocarcinoma (n=180) 
 
 
Characteristic 
 
Person-
years 
Cases 
n 
 
HR 
(95%CI) 
Adjusteda HR 
(95% CI) 
Cases
n 
 
HR 
(95%CI) 
Adjusteda HR 
(95% CI) 
Cases 
n 
 
HR 
(95%CI) 
Adjusteda HR 
(95% CI) 
Male pattern baldness           
No 383,248 73  Ref Ref 9 Ref Ref 41 Ref Ref 
Yes 799,540 175  1.00 (0.76, 1.31) 1.02 (0.77, 1.36) 30  1.35 (0.64, 2.85) 1.35 (0.63, 2.87) 135 1.36 (0.96, 1.94) 1.36 (0.95, 1.95) 
Missing  5   0   4   
Male pattern baldness pattern 
No baldness 383,248 73  Ref Ref 9 Ref Ref 41 Ref Ref 
Frontal only 272,458 48  0.94 (0.66, 1.36) 0.98 (0.68, 1.43) 5 0.80 (0.27, 2.39) 0.79 (0.26, 2.36) 41 1.42 (0.92, 2.19) 1.47 (0.94, 2.28) 
Frontal and mild vertex 313,218 72  0.97 (0.70, 1.34) 0.98 (0.70, 1.38) 17  1.79 (0.80, 4.03) 1.78 (0.78, 4.06) 56 1.34 (0.89, 2.01) 1.28 (0.84, 1.94) 
Frontal and severe vertex 213,863 55  1.10 (0.77, 1.56) 1.13 (0.78, 1.62) 8  1.25 (0.48, 3.26) 1.32 (0.51, 3.45) 38 1.34 (0.86, 2.09) 1.35 (0.86, 2.14) 
Missing  5  Ptrend=0.60 0  Ptrend=0.26 4  Ptrend=0.25 
Fathered children           
No 248,723 40  Ref Ref 11  Ref Ref 30 Ref Ref 
Yes 934,168 207  1.07 (0.76, 1.51) 1.07 (0.75, 1.53) 27  0.48 (0.24, 0.97) 0.56 (0.27, 1.15) 146 1.01 (0.68, 1.49) 1.10 (0.72, 1.68) 
Missing  6   1   4   
Number of children fathered 
0 248,723 40  Ref Ref 11  Ref Ref  Ref Ref 
1 151,412 34  1.24 (0.78, 1.96) 1.19 (0.74, 1.91) 5  0.64 (0.22, 1.84) 0.70 (0.24, 2.03) 30 1.21 (0.71, 2.06) 1.29 (0.74, 2.25) 
2 495,538 104  1.00 (0.69, 1.45) 1.04 (0.71, 1.53) 12  0.40 (0.17, 0.91) 0.52 (0.23, 1.22) 25 0.86 (0.56, 1.33) 0.98 (0.62, 1.56) 
3+ 287,217 69 1.12 (0.75, 1.65) 1.05 (0.70, 1.59) 10  0.55 (0.23, 1.30) 0.54 (0.22, 1.32) 121 1.14 (0.73, 1.80) 1.18 (0.74, 1.90) 
Missing  6  Ptrend=0.98 1  Ptrend=0.14 4  Ptrend=0.72 
Relative age at first facial hair 
Younger than average 78,766 17  Ref Ref 1  Ref Ref 6 Ref Ref 
About average age 918,381 204  0.81 (0.50, 1.34) 0.82 (0.50, 1.35) 31  2.03 (0.28, 14.94) 1.94 (0.26, 14.26) 114 1.64 (0.72, 3.72) 1.60 (0.71, 3.64) 
Older than average 149,263 19  0.57 (0.30, 1.09) 0.56 (0.29, 1.10) 5  2.53 (0.30, 21.67) 2.25 (0.26, 19.29) 17 1.45 (0.57, 3.69) 1.54 (0.61, 3.91) 
Missing  13  Ptrend=0.08 2  Ptrend=0.50 13  Ptrend=0.54 
Relative age voice broke 
Younger than average 48,226 12  Ref Ref 2 Ref Ref 4 Ref Ref 
About average age 980,197 206  0.67 (0.37, 1.19) 0.66 (0.37, 1.19) 29 0.56 (0.13, 2.34) 0.56 (0.13, 2.35) 147 1.45 (0.53, 3.91) 1.47 (0.54, 3.99) 
Older than average 65,391 14  0.84 (0.39, 1.81) 1.01 (0.46, 2.19) 0 - - 6 1.08 (0.30, 3.82) 1.25 (0.35, 4.45) 
Missing  21  Ptrend=0.87 8   23  Ptrend=0.81 
Table 4. Hormonal and reproductive factors and risk of gastric cancer by tumour location in 
men within the UK Biobank 
 
    
Gastric cardia  (n=101) 
   
Gastric non-cardia (n=52) 
 
 
Characteristic 
Person-
years 
 
Cases  
n   
 
 
HR 
(95%CI) 
Adjusteda HR 
(95% CI) 
 
Cases 
n   
 
 
HR 
(95%CI) 
Adjusteda HR 
(95% CI) 
Male pattern baldness        
No 383,248 21 Ref Ref 12 Ref Ref 
Yes 799,540 78 1.55 (0.96, 2.52) 1.59 (0.97, 2.61) 39 1.37 (0.71, 2.62) 1.13 (0.72, 1.76) 
Missing  2   1   
Male pattern baldness 
pattern 
  
  
 
  
No baldness 383,248 21 Ref Ref 12 Ref Ref 
Frontal only 272,458 22  1.50 (0.82, 2.72) 1.61 (0.88, 2.95) 16 1.89 (0.89, 3.99) 1.40 (0.82, 2.39) 
Frontal and mild vertex 313,218 33  1.56 (0.90, 2.70) 1.59 (0.90, 2.79) 14 1.16 (0.54, 2.52) 1.01 (0.59, 1.72) 
Frontal and severe vertex 213,863 23 1.61 (0.89, 2.91) 1.58 (0.86, 2.93) 9 1.10 (0.46, 2.63) 1.01 (0.56, 1.82) 
Missing  2  Ptrend=0.14 1  Ptrend=0.81 
Fathered children        
No 248,723 21 Ref Ref 10 Ref Ref 
Yes 934,168 80  0.79 (0.49, 1.29) 0.83 (0.50, 1.39) 39 0.83 (0.41, 1.67) 1.41 (0.79, 2.51) 
Missing  0   3   
Number of children fathered 
0 248,723 21  Ref Ref 10 Ref Ref 
a Adjusted for socioeconomic status, alcohol status, smoking status, BMI, waist-hip ratio and fruit and vegetable 
intake  
 
1 151,412 12  0.83 (0.41, 1.69) 0.87 (0.42, 1.81) 7 1.03 (0.39, 2.71) 1.55 (0.74, 3.27) 
2 495,538 36  0.67 (0.39, 1.14) 0.73 (0.41, 1.30) 32 0.76 (0.35, 1.64) 1.38 (0.75, 2.56) 
3+ 287,217 32 0.99 (0.57, 1.72) 0.96 (0.54, 1.72) 3 0.85 (0.37, 1.95) 1.38 (0.72, 2.64) 
Missing  0  Ptrend=0.84   Ptrend=0.44 
Relative age at first facial hair 
Younger than average 78,766 3  Ref Ref 3 Ref Ref 
About average age 918,381 84  1.92 (0.61, 6.08) 1.94 (0.61, 6.17) 40 0.93 (0.29, 3.03) 1.91 (0.60, 6.06) 
Older than average 149,263 11 1.88 (0.52, 6.73) 2.04 (0.57, 7.34) 5 0.86 (0.20, 3.58) 1.56 (0.42, 5.77) 
Missing  3  Ptrend=0.38 4  Ptrend=0.81 
Relative age voice broke        
Younger than average 48,226 1  Ref Ref 0 Ref Ref 
About average age 980,197 90  - - 41 1.13 (0.36, 5.59) 1.11 (0.35, 3.52) 
Older than average 65,391 4   2 0.96 (0.21, 4.29) 1.04 (0.23, 4.66) 
Missing  6      
